Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus
This study has been completed.
Study NCT01030679   Information provided by Chong Kun Dang Pharmaceutical

First Received on December 9, 2009.   Last Updated on December 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
CKD-501 0.5mg
CKD-501 1mg
CKD-501 2mg
Placebo
Sponsors listed in this trial
Chong Kun Dang Pharmaceutical


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services